Profile
Mr. Clement Loh is Investment Analyst at Anson Advisors, Inc.
Prior to joining Anson Group in 2010, Mr. Loh was employed as a Drug Safety Associate by Janssen-Ortho, Inc.
Mr. Loh earned his BS in Pharmacy and MBA in Finance from The University of Toronto.
Former positions of Clement Loh
Companies | Position | End |
---|---|---|
Janssen, Inc.
Janssen, Inc. Pharmaceuticals: MajorHealth Technology Janssen, Inc. operates as a pharmaceutical company of Johnson & Johnson. Its products include Caelyx, Concerta, Cyclen, Ditropan XL, Duragesic, Edurant, Evra, Galexos, Invega, Invokana, Jurnista, Livostin, Pariet, Remicade, Sylvant, Topamax, Ultram, Velcade, Yondelis, and Zytiga. The company is headquartered in Toronto, Canada. | Corporate Officer/Principal | 2007-12-31 |
Anson Advisors, Inc.
Anson Advisors, Inc. Investment ManagersFinance Anson Advisors, Inc. is a privately-held alternative asset management firm headquartered in Toronto, Canada. The firm was founded in 2003 as M5V Advisors, Inc. Anson Advisors serves as the investment manager to privately-held onshore investment partnerships and offshore investment companies. Anson Investments Master Fund (AIMF) is their flagship fund. | Analyst-Equity | - |
Training of Clement Loh
University of Toronto | Masters Business Admin |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
Private companies | 2 |
---|---|
Anson Advisors, Inc.
Anson Advisors, Inc. Investment ManagersFinance Anson Advisors, Inc. is a privately-held alternative asset management firm headquartered in Toronto, Canada. The firm was founded in 2003 as M5V Advisors, Inc. Anson Advisors serves as the investment manager to privately-held onshore investment partnerships and offshore investment companies. Anson Investments Master Fund (AIMF) is their flagship fund. | Finance |
Janssen, Inc.
Janssen, Inc. Pharmaceuticals: MajorHealth Technology Janssen, Inc. operates as a pharmaceutical company of Johnson & Johnson. Its products include Caelyx, Concerta, Cyclen, Ditropan XL, Duragesic, Edurant, Evra, Galexos, Invega, Invokana, Jurnista, Livostin, Pariet, Remicade, Sylvant, Topamax, Ultram, Velcade, Yondelis, and Zytiga. The company is headquartered in Toronto, Canada. | Health Technology |
- Stock Market
- Insiders
- Clement Loh